Valuation : GENFIT

Market Cap 685M 795M 649M 588M 1.1B 75.99B 1.11B 7.71B 2.96B 38.66B 2.99B 2.92B 122B P/E 2026 *
35.3x
P/E 2027 * 78.1x
Enterprise Value 634M 736M 601M 544M 1.02B 70.32B 1.03B 7.13B 2.74B 35.78B 2.76B 2.7B 113B EV / Sales 2026 *
6.32x
EV / Sales 2027 * 4.94x
Free-Float
86.89%
Yield 2026 *
-
Yield 2027 * -
1 day-4.96%
1 week-5.52%
Current month-7.92%
1 month+0.46%
3 months+47.62%
6 months+45.23%
Current year+147.29%
1 week 12.3
Extreme 12.3
14.5
1 month 12.3
Extreme 12.3
14.98
Current year 5.05
Extreme 5.05
15.48
1 year 3.05
Extreme 3.048
15.48
3 years 2.62
Extreme 2.62
15.48
5 years 2.62
Extreme 2.62
15.48
10 years 2.62
Extreme 2.62
35.65
Manager TitleAgeSince
Chief Executive Officer 58 16/09/2019
Director of Finance/CFO 52 22/04/2021
Chief Tech/Sci/R&D Officer - 27/11/2025
Director TitleAgeSince
Chairman 70 16/06/2017
Director/Board Member 54 15/09/1999
Director/Board Member 58 16/06/2017
Date Insider Type Main position Quantity % Market Cap. Importance
5/3/26 Exercice

Chief Operating Officer

11,250 0.0225%
5/3/26 Exercice

Chief Operating Officer

7,083 0.0142%
5/3/26 Sell

Chief Operating Officer

7,083 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
-4.96%-5.52%+260.66%+239.95% 797M
-0.71%-6.35%-4.87%+9.03% 46.05B
+0.24%-2.91%+340.98%+520.35% 43.59B
+1.68%-2.40%+37.05%+21.37% 42.35B
+1.21%-3.48%+3.01%+65.26% 38.86B
-1.44%-4.76%+10.26%+38.52% 32.24B
+0.86%-2.40% - - 17.16B
+1.18%+0.00%+18.83%+111.67% 16.28B
-0.31%-2.78%+10.47%+30.49% 14.32B
+1.90%-3.79%+73.77%+39.03% 13.03B
Average -0.10%-4.39%+83.35%+119.52% 26.47B
Weighted average by Cap. +0.24%-5.09%+73.85%+124.17%

Financials

2026 *2027 *
Net sales 100M 116M 94.96M 86.07M 161M 11.12B 162M 1.13B 434M 5.66B 437M 428M 17.88B 125M 146M 119M 108M 202M 13.91B 203M 1.41B 542M 7.07B 547M 535M 22.36B
Net income 22.88M 26.55M 21.66M 19.63M 36.84M 2.54B 37.02M 257M 98.94M 1.29B 99.72M 97.53M 4.08B 6.8M 7.89M 6.44M 5.84M 10.95M 754M 11M 76.47M 29.41M 384M 29.64M 28.99M 1.21B
Net Debt -51.11M -59.32M -48.39M -43.86M -82.29M -5.67B -82.7M -575M -221M -2.88B -223M -218M -9.11B -65.86M -76.44M -62.36M -56.52M -106M -7.3B -107M -741M -285M -3.72B -287M -281M -11.74B
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
161
Date Price Change Volume
11/09/26 13.02 -4.96% 424,279
10/09/26 €13.70 +11.38% 475,388
09/09/26 €12.30 -6.11% 255,773
08/09/26 €13.10 -3.53% 372,470
07/09/26 €13.58 -1.45% 160,877
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
13.70EUR
Average target price
17.15EUR
Spread / Average Target
+25.18%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GNFT Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!